- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.11. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 127 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
| 20.11. | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 94 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 20.11. | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 340 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
| ZICCUM Aktie jetzt für 0€ handeln | |||||
| 29.10. | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 109 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
| 10.10. | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 102 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 30.08. | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 142 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen | |
| 29.04. | Ziccum AB: Ziccum AB (publ) Interim report Q1 2024 | 74 | GlobeNewswire (Europe) | INTERIM REPORT Q1, 1 JANUARY - 31 MARCH 2024
Significant events during the QuarterSuccessful outcomes of LaminarPace Feasibility study with Biotech partnerOn January 10, the company announced that,... ► Artikel lesen | |
| 06.03. | Nasdaq Stockholm AB: New equity right for trading, Ziccum AB TO5 (114/24) | 259 | GlobeNewswire | At the request of Ziccum AB, Ziccum AB equity rights will be traded on First
North Growth Market as from March 7, 2024.
Security name: Ziccum AB TO5
-----------------------------
Short name: ZICC... ► Artikel lesen | |
| 29.02. | Nasdaq Stockholm AB: Delising of paid subscription units of Ziccum AB from First North Growth Market (100/24) | 352 | GlobeNewswire | Last day of trading in paid subscription units (BTA) of Ziccum AB
Trading in Ziccum AB paid subscription units is to cease. The last trading day
is March 1, 2024.
Short name: ZICC BTU
---------------------------
ISIN... ► Artikel lesen | |
| 30.01. | Nasdaq Stockholm AB: Listing of unit rights and subscription units of Ziccum AB (44/24) | 359 | GlobeNewswire | With effect from January 31, 2024, the unit rights in Ziccum AB will be traded
on First North Growth Market. Trading will continue up until and including
February 09, 2024.
Instrument: Unit rights... ► Artikel lesen | |
| 26.01. | Ziccum AB: Year-End report Q4 2023 | 514 | GlobeNewswire (Europe) | YEAR-END REPORT Q4 2023: 1 JANUARY - 31 DECEMBER 2023
Significant events during the QuarterCollaboration agreement with University of CopenhagenOn December 4th, the company announced that it had signed... ► Artikel lesen | |
| 26.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 26.01.2024 | 692 | Xetra Newsboard | Das Instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 26.01.2024 und ex Kapitalmassnahme am 29.01.2024 The instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 33,200 | -0,84 % | Fresenius SE Aktie: Positiver Umsatztrend! | Die Fresenius SE-Aktie zeigt sich im aktuellen Handelsverlauf an der XETRA mit wechselhafter Tendenz. Nach einem Handelsstart bei 34,92 EUR bewegte sich der Kurs im Tagesverlauf zwischen verschiedenen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,10 | -0,72 % | Nach Siemens-Energy-Boom: Startet als nächstes die Siemens-Healthineers-Aktie durch? | Ein starkes Schlussquartal und ein optimistischer Ausblick des Medizintechnikers Siemens Healthineers sollten der Aktie genug Rückenwind liefern, auf den Anleger gehebelt setzen können. So funktioniert's.... ► Artikel lesen | |
| THERMO FISHER | 500,50 | -0,38 % | Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific | LAKEWOOD, N.J.--(BUSINESS WIRE)--Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 48,250 | -0,66 % | Eurofins Scientific SE: Eurofins Launches Fourth Buy-Back Programme of Its Own Shares | Regulatory News:
Eurofins Scientific SE (Paris:ERF) (the "Company") (EUFI.PA) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount... ► Artikel lesen | |
| SYNLAB | 11,220 | -0,53 % | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| DAVITA | 146,65 | +0,69 % | DaVita Stock Sees Improved Relative Strength Rating | ||
| DENTSPLY SIRONA | 17,970 | +0,25 % | Dentsply Sirona Appoints Herman Cueto As Interim CFO | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc. (XRAY), a maker of dental products, announced on Tuesday that it has appointed Herman Cueto as interim chief financial officer, with immediate... ► Artikel lesen | |
| SMITH & NEPHEW | 11,900 | +0,89 % | Smith & Nephew UK Ltd: Smith+Nephew introduces CORIOGRAPH Pre-Op Planning and Modeling Services for Total Hip Arthroplasty | Latest expansion to the CORI? Surgical System portfolio provides a personalized solution for patients and surgeons
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today... ► Artikel lesen | |
| SONIC HEALTHCARE | 16,832 | +1,40 % | SONIC HEALTHCARE LIMITED: Change of Director's Interest Notice | ||
| DIASORIN | 100,00 | -0,05 % | Milan: Major selling for DiaSorin | ||
| PATTERSON COMPANIES | 29,400 | -1,34 % | Patient Square Capital Buying Patterson Companies In $4.1 Billion Deal | ||
| FULGENT GENETICS | 18,000 | +2,27 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| IMPLANTICA | 3,160 | -0,32 % | Implantica strengthens the strategic RefluxStop expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline | VADUZ, Liechtenstein, Dec. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,640 | -4,35 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society ... | [212Pb]VMT-a-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and 5.0 mCi)Eight of nine patients had durable control of disease.... ► Artikel lesen | |
| OMNICELL | 42,200 | -2,31 % | Omnicell Announces Third Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen |
Das Unternehmen ZICCUM AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,018 Euro und damit +9,64 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZICCUM AB finden Sie auf Wallstreet Online.
